6. Singer RS, Finch R, Wegener HC, Bywater R, Walters J, Lipsitch M. Antibiotic resistance-the interplay between antibiotic use in animals and human beings. Lancet Infect Dis 2003;3:47–51.
https://doi.org/10.1016/S1473-3099(03)00490-0
10. Kantas D, Papatsiros VG, Tassis PD, Athanasiou LV, Tzika ED. The effect of a natural feed additive (Macleaya cordata), containing sanguinarine, on the performance and health status of weaning pigs. Anim Sci J 2015;86:92–8.
https://doi.org/10.1111/asj.12240
15. Qu J, Wang W, Zhang Q, Li S. Inhibition of Lipopolysaccharide-induced inflammation of chicken liver tissue by selenomethionine via TLR4-NF-κB-NLRP3 signaling pathway. Biol Trace Elem Res 2020;195:205–14.
https://doi.org/10.1007/s12011-019-01841-0
18. Takahashi K, Takimoto T, Sato K, Akiba Y. Effect of dietary supplementation of astaxanthin from Phaffia rhodozyma on lipopolysaccharide-induced early inflammatory responses in male broiler chickens (Gallus gallus) fed a corn-enriched diet. Anim Sci J 2011;82:753–8.
https://doi.org/10.1111/j.1740-0929.2011.00898.x
22. Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 2008;47:1363–70.
https://doi.org/10.1002/hep.22109
23. Senior JR. Alanine aminotransferase: a clinical and regulatory tool for detecting liver injury–past, present, and future. Clin Pharmacol Ther 2012;92:332–9.
https://doi.org/10.1038/clpt.2012.108
25. Qin X, Gao B. The complement system in liver diseases. Cell Mol Immunol 2006;3:333–40.
26. Thorgersen EB, Barratt-Due A, Haugaa H, et al. The role of complement in liver injury, regeneration, and transplantation. Hepatology 2019;70:725–36.
https://doi.org/10.1002/hep.30508
29. Lin C, Lei B, Dong C, et al. Complement inhibition alleviates donor brain death-induced liver injury and posttransplant cascade injury by regulating phosphoinositide 3-kinase signaling. Am J Transplant 2023;23:484–97.
https://doi.org/10.1016/j.ajt.2023.01.019
35. Umaya SR, Vijayalakshmi YC, Sejian V. Exploration of plant products and phytochemicals against aflatoxin toxicity in broiler chicken production: Present status. Toxicon 2021;200:55–68.
https://doi.org/10.1016/j.toxicon.2021.06.017
36. Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301–10.
https://doi.org/10.1056/NEJMoa064278
42. Wallenius V, Wallenius K, Hisaoka M, et al. Retarded liver growth in interleukin-6-deficient and tumor necrosis factor receptor-1-deficient mice. Endocrinology 2001;142:2953–60.
https://doi.org/10.1210/endo.142.7.8270
45. Treffkorn L, Scheibe R, Maruyama T, Dieter P. PGE2 exerts its effect on the LPS-induced release of TNF-alpha, ET-1, IL-1alpha, IL-6 and IL-10 via the EP2 and EP4 receptor in rat liver macrophages. Prostaglandins Other Lipid Mediat 2004;74:113–23.
https://doi.org/10.1016/j.prostaglandins.2004.07.005
46. Jndoyan ZT, Bablumyan AY, Ginosyan KV, Shekoyan SV. Correlations between indicators of interleukin-10 and interleukin-6 in patients with periodic disease. Ter Arkh 2018;90:38–41.
https://doi.org/10.26442/terarkh201890338-41
48. Kong F, Ye B, Lin L, Cai X, Huang W, Huang Z. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes. Biomed Pharmacother 2016;82:167–72.
https://doi.org/10.1016/j.biopha.2016.04.043
53. Wu M, Liu X, Chen H, et al. Activation of pyroptosis by membrane-anchoring AIE photosensitizer design: New prospect for photodynamic cancer cell ablation. Angew Chem Int Ed 2021;60:9093–8.
https://doi.org/10.1002/anie.202016399